Product & regulatory approvals
Gates that opened: regulatory and product approvals — drug approvals, licences, clearances — disclosed to the exchanges inside the window. The approval filing is linked on every row.
| Company | Why it’s here — the filing | Reaction 1d / 1w / 1m | Price | Mcap |
|---|---|---|---|---|
| USFDA inspection closed with zero observations at Hyderabad facility | +5.8% +8.0% — | ₹73.35 | 146 Cr | |
| Kwality Pharma gets CDSCO nod for Pembroluzimab preclinical batches | +1.2% -3.0% — | ₹3,350 | 3,476 Cr |
Page 2 of 2Previous
How this list is built
A company appears when an NSE/BSE filing inside the last 30 days carries one of these classifier signals (minimum importance: Medium): Regulatory Product Approval. Each row shows the latest qualifying filing; the reaction columns are the stock’s measured move 1 day, 1 week and 1 month after that filing.
MarketPing publishes facts, filings and measured history only — nothing on this page is investment advice, a recommendation or a rating.